Literature DB >> 11745774

Enantiomeric drug development: issues, considerations, and regulatory requirements.

N R Srinivas1, R H Barbhaiya, K K Midha.   

Abstract

Mesh：

Year:  2001        PMID： 11745774     DOI： 10.1002/jps.1074

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  6 in total

Review 1.  Evolution of stimulants to treat ADHD: transdermal methylphenidate.

Authors:  Kennerly S Patrick; Arthur B Straughn; Jeb S Perkins; Mario A González
Journal:  Hum Psychopharmacol       Date:  2009-01       Impact factor: 1.672

2.  Hepatic Organoid-Based High-Content Imaging Boosts Evaluation of Stereoisomerism-Dependent Hepatotoxicity of Stilbenes in Herbal Medicines.

Authors:  Juan Liu; Tingting Li; Ruihong Li; Jie Wang; Pengyan Li; Ming Niu; Le Zhang; Chunyu Li; Tao Wang; Xiaohe Xiao; Jia-Bo Wang; Yunfang Wang
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

3.  Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress.

Authors:  Ashley Bernardo; Philip Lee; Michael Marcotte; Md Yeunus Mian; Sepideh Rezvanian; Dishary Sharmin; Aleksandra Kovačević; Miroslav M Savić; James M Cook; Etienne Sibille; Thomas D Prevot
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 8.294

Review 4.  Design, Development, and Analysis of an Automated Sampling Loop for Online Monitoring of Chiral Crystallization.

Authors:  Ghufran Ur Rehman; Thomas Vetter; Philip A Martin
Journal:  Org Process Res Dev       Date:  2022-02-15       Impact factor: 3.858

5.  Antipsychotic Benzamides Amisulpride and LB-102 Display Polypharmacy as Racemates, S Enantiomers Engage Receptors D2 and D3, while R Enantiomers Engage 5-HT7.

Authors:  Vincent Grattan; Andrew R Vaino; Zachary Prensky; Mark S Hixon
Journal:  ACS Omega       Date:  2019-08-15

6.  Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis.

Authors:  Stephen Robert Chapman; Mohammed Ibrahim Aladul; Raymond William Fitzpatrick
Journal:  BMJ Open       Date:  2019-08-01       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.